LIMD1 and lung cancer: Taken together, our findings hold significant impact for the aetiology of LIMD1‐negative lung cancers and hold the potential for advances in the diagnosis and prognosis of such cancers with respect to deregulated HIF regulation and associated oncogenic phenotypes, and subsequently hypoxia‐targeted therapies.